In working-age adults, diabetic retinopathy (a condition that affects those with diabetes) is the leading cause of vision impairment. Over time, diabetes can damage blood vessels in the retina, eventually causing the vessels to leak blood and other fluids. This results in cloudy and blurred vision, which can be treated but not cured. For the best possible outcome, diabetic patients should come in for a yearly diabetic retinopathy screening, which can detect the condition in its early stages and limit the amount of vision loss that patient will experience. This is where the Welch Allyn RetinaVue 100 Imager can significantly help your practice.
The RetinaVue 100 Imager uses a simple and affordable four-step process to accurately screen for diabetic retinopathy. Results are provided the same day, usually within just 90 minutes. Because this screening device can detect the condition early, it can save patients large sums of money in treatment costs. The national average reimbursement to use this service is $75 per exam, helping hospitals save money, too.
Improve patient care in your practice by offering diabetic retinopathy screening. You can find the RetinaVue 100 Imager, and more important equipment, for an affordable cost at Medical Device Depot today.